Concepedia

Richard Van Inwegen

RV

Statistics

Publications

5

Citations

133

H-Index

5

Active since

1983

Affiliations

Clinical Solutions(Current)

Tufts University

Richard Van Inwegen is an author at Clinical Solutions specializing in pharmacology, medicinal chemistry, and 5-lipoxygenase inhibition.

Publications per year

1983–2016

5

Publications

5

Substituted arylmethyl phenyl ethers. 1. A novel series of 5-lipoxygenase inhibitors and leukotriene antagonists

JOHN H. MUSSER, Utpal Chakraborty, Stanley Sciortino et al. · Journal of Medicinal Chemistry · 1987 · 51 citations · Full text

, , +14

Assessment of Pain and Activity Using an Electronic Pain Diary and Actigraphy Device in a Randomized, Placebo‐Controlled Crossover Trial of Celecoxib in Osteoarthritis of the Knee

Jeremiah Trudeau, Richard Van Inwegen, Thomas A. Eaton et al. · Pain Practice · 2014 · 38 citations

, , +17

Arylmethyl Phenyl Ethers A New Class of Specific Inhibitors of 5-Lipoxygenase

Stephen M. Coutts, Atul Khandwala, Richard Van Inwegen et al. · 1985 · 22 citations

, , +6

Antiallergic activity profile in vitro of RHC 2963 and related compounds

Atul Khandwala, Richard Van Inwegen, Stephen M. Coutts et al. · International Journal of Immunopharmacology · 1983 · 12 citations

, , +4

Development and feasibility of the misuse, abuse, and diversion drug event reporting system (MADDERS®)

Roi Treister, Jeremiah Trudeau, Richard Van Inwegen et al. · American Journal on Addictions · 2016 · 10 citations · Full text

, , +16

1–5 of 5